Drug profile · INN
erythropoietin
erythropoietin is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 5
Pipeline programs 12
News articles 0
Drug details — erythropoietin
- Class
- —
- Route
- —
- Patents
- 5
- Programs
- 12
- Data quality
- 0.70
Quick answer
erythropoietin is an FDA-listed pharmaceutical active ingredient.
Key facts
INN erythropoietin
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
US 11197812
Cosmetic formulations for topical applications containing erythropoietin-derived molecules
granted -
US 10912791
Compositions comprising antisense-encoded erythropoietin receptor and use thereof
granted -
US 10456346
Cosmetic formulations for topical applications containing erythropoietin-derived molecules
granted -
US 10233452
Compositions and methods for increasing erythropoietin (EPO) production
granted -
US 7300915
Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
granted
Frequently asked questions
What is erythropoietin?
erythropoietin is an FDA-listed pharmaceutical active ingredient.